5' Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 1 I, 2000, Pages 72-76

  Van Sambeek, Rachel ^a   Stevenson, Donald D ^c   Baldasaro, Mathew ^a   Lam, Bing K ^a   Zhao, Jiliang ^a   Yoshida, Satoshi ^b   Yandora, Chandri ^b   Drazen, Jeffrey M ^b   Penrose, John F ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Aspirin intolerant asthma; Cysteinyl leukotrienes; Leukotriene C4 synthase; Polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; ADENINE; CYTOSINE; LEUKOTRIENE C4 SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDOLEUKOTRIENE;

ALLELE; ARTICLE; ASTHMA; BIOSYNTHESIS; DNA POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNITED STATES;

EID: 0033941793     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.107603     Document Type: Article

References (24)

1. Szczeklik A. Mechanism of aspirin-induced asthma. Allergy 1997;52:613-9.
2. 4 and histamine in asthmatics. Am Rev Respir Dis 1992;146:96-103
3. 4 concentration increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:1025-9.
4. 4 during aspirin-induced asthma. J Lab Clin Med 1992;119:48-51
5. Dahlen B, Kumlin M, Margolskee DJ, et al. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur Respir J 1993;6:1018-26.
6. Israel E, Fischer AR, Rosenberg MA, et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 1993;148:1447-51.
7. Dahlen B, Margolskee DJ, Zetterstrom O, Dahlen SE. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects. Thorax 1993;48:1205-10.
8. 2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 1991;65:1043-51.
9. Abramovitz M, Wong E, Cox ME, Richardson CD, LI C, Vickers PJ. 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoyxgenase. Eur J Biochem 1993;215:105-11.
10. 4 synthase activities. Proc Natl Acad Sci USA. 1986;83:857-61.
11. 4 synthetase of rat basophil leukemia cells: a novel, particulate glutathione S-transferase. Arch Biochem Biophys 1984;230:455-65.
12. 4 synthase, a pivotal enzyme in the biosynthesis of cysteinyl leukotrienes. In: Drazen J, Dahlen S-E, Lee T, eds. Five lipoxygenase products in asthma. New York: Marcel Dekker, Inc; 1998. p. 33-49.
13. 4 by human eosinophils. J Biol Chem 1989;264:12885-9.
14. 4 gamma-glutamyl amino acid. Proc Natl Acad Sci USA 1982;79:1088-91.
15. 4 by a dipeptidase released from the specific granules of human polymorphonuclear leukocytes. Immunology 1983;48:27-35.
16. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101:834-46.
17. 4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997;350:599-600.
18. Stevenson DD. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Middleton E Jr, Ellis EF, Yunginger JW, Reed CE, Adkinson NF Jr, Busse WW, eds. Allergy: principles and practice. St Louis: Mosby; 1998. p. 1225-34.
19. Weir BS. Genetic data analysis II. Suncerland (MA): Sinauer Associates, Inc; 1996.
20. 4 synthase activity in differentiating human erythroleukemia cells. Biochem Biophys Res Commun 1992;189:1043-9.
21. 4 synthase activity in human platelets. Eur J Biochem 1996;243:513-20.
22. 4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol 1999;104:559-64.
23. Hijazi Z, Haider MZ, Khan MR, Al-Dowaisan AA. High frequency of IgE receptor Fc epsilon RI beta variant (Leu181/Leu183) in Kuwaiti Arabs and its association with asthma. Clin Genet 1998;53:149-52.
24. Stafforini DM, Numao T, Tsodikov A, et al. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J Clin Invest 1999;103:989-97.